• Products
  • Manufacturing Services
  • Quality
  • Knowledge Center
  • About Us

Blog

Showing 30 of 30 blog

May 14, 2024

Reducing the Complexity, Time, Risk, and Cost of Media Formulation in Cell Therapy Manufacturing

 Read More
Feb 13, 2023

Comparable Advantages of IL-2 Ancillary Material Use Over Pharmaceutical Reagents within Cell Therapy Manufacturing

 Read More
Jun 03, 2021

Mitigating unintentional effects of pharmaceutical human serum albumin preparations in therapeutic cell culture

 Read More
Mar 26, 2021

Enhancing the safety of virus-inactivated ancillary materials through neutralizing antibodies

 Read More
Mar 10, 2021

Going Green, the Akron Way

 Read More
Feb 25, 2021

Reducing Variability in Cytokine Activity Reporting

 Read More
Jan 20, 2021

Safety First: Methods of virus inactivation for increased safety of advanced therapies

 Read More
Dec 16, 2020

Cryopreservation During the Holidays

 Read More
May 06, 2020

Building a resilient cell and gene therapy industry in the face of COVID-19

 Read More
Apr 06, 2020

The importance of cytokine and growth factor purity in cell therapy development and manufacturing

 Read More
Feb 18, 2020

Building a Robust Supply Chain to Enable Cell and Gene Therapy Development

 Read More
Nov 18, 2019

Superiority, Non-inferiority and Equivalence – The Phase III Question

 Read More